Back to All Events

Oslo Diabetes Research Centre: Research Seminar 2024

Venue: Stort møterom, Georg Sverdrups hus (University Library), UiO, Blindern, Oslo

08.30 WELCOME, Kåre I. Birkeland

TOPIC I: OMICS IN DIABETES RESEARCH Chair: Lars Christian Stene

08.45 Key note lecture I: MULTI-OMICS IN PRECICTION OF INCIDENT TYPE 2 DIABETES, Nick Wareham MRC, Cambridge, UK

09.30 Invited lecture: OMICS ANALYSES AT THE NORWEGIAN SEQUENCING CENTRE, Gregor Gifillan, OUS node at the Norwegian Sequencing Centre

10.00 ODF-presentation: CAN CHANGES IN INSULIN RESISTANCE AFTER EXERCISE TRAINING BE PREDICTED BY ARTIFICIAL INTELLIGENCE BASED ON LARGE-SCALE SERUM PROTEOMICS?, Sindre Lee-Ødegård

10.15    General discussion    

10.30    Coffee break

TOPIC II: TYPE 1 DIABETES AND COMPLICATIONS, Chair: Tore Julsrud Berg

11.00 Key note lecture II: LESSONS FROM THE LARGE NATIONWIDE FINNDIANE STUDY, Per-Henrik Groop, University of Helsinki, Finland

11.45 ODF-presentation: END-STAGE RENAL DISEASE: INCIDENCE AND PREDICTION BY CORONARY HEART DISEASE, AND EDUCATIONAL LEVEL. FOLLOW-UP FROM DIAGNOSIS OF CHILDHOOD-ONSET TYPE 1 DIABETES THROUGHOUT NORWAY 1973-2017, Maryam Saeed

12.00, ODF-presentation: INTESTINAL FATTY ACID BINDING PROTEIN IS ASSOCIATED WITH CORONARY ARTERY DISEASE IN LONG-TERM TYPE 1 DIABETES. THE DIALONG STUDY, Marte Narum

12.15 LUNCH 

TOPIC III: DIABETES AND EATING, Chair: Line Wisting

13.15 Key note lecture III: “I HAVEN’T TOLD ANYONE BUT YOU”: ASSESSING AND ADDRESSING BINGE EATING IN PEOPLE WITH TYPE 2 DIABETES, Pil Lindgreen, Steno Research Center, Copenhagen

14.00 ODF-presentation: DIABETES BODY PROJECT: SHORT-TERM EFFECTS OF AN EATING DISORDER PREVENTION PROGRAM FOR YOUNG FEMALES WITH TYPE 1 DIABETES, Severina Haugsvik

14.15 ODF-presentation: DIAMESTER, Anne Marie Aas

14.30 General discussion          

14.45 Coffee break      

TOPIC IV: PREVENTION OF TYPE 1 DIABETES, Chair: Lars Krogvold

15.00 Key note lecture IV: SCREENING AND PREVENTION OF TYPE 1 DIABETES, Helena Elding Larsson, CRC, Lund University, Malmö, Sweden

15.45 ODF-presentation: Long-term results of the DIVID-intervention study, Ida Maria Mynarek

16.00, ODF-presentations: PLANS FOR A NEW CLINICAL INTERVENTION STUDIES              

16.15 COMBINATION OF ANTIVIRAL AND IMMUNOMODULATION THERAPY FOR PREVENTION OF TYPE 1 DIABETES, Knut Dahl-Jørgensen

16.30 DECIDUAL STROMAL CELL THERAPY IN NEW-ONSET TYPE 1 DIABETES: A STRATEGY TO PROTECT AND PRESERVE CELLS, Hanne Scholz

16.45    General discussion          

17.00    COFFEE BREAK  

17.30    GENERAL ASSEMBLY      

18.30    DINNER OR TAPAS

Earlier Event: November 16
Centre Meeting
Later Event: September 2
Public Defence